- Home
- PTGX vs BNL Comparison
PTGX vs BNL Comparison
Compare PTGX & BNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- BNL
- Stock Information
- Founded
- PTGX 2006
- BNL 2007
- Country
- PTGX United States
- BNL United States
- Employees
- PTGX N/A
- BNL N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- BNL Real Estate Investment Trusts
- Sector
- PTGX Health Care
- BNL Real Estate
- Exchange
- PTGX Nasdaq
- BNL Nasdaq
- Market Cap
- PTGX 3.3B
- BNL 3.0B
- IPO Year
- PTGX 2016
- BNL 2020
- Fundamental
- Price
- PTGX $53.00
- BNL $16.08
- Analyst Decision
- PTGX Strong Buy
- BNL Hold
- Analyst Count
- PTGX 9
- BNL 5
- Target Price
- PTGX $67.11
- BNL $18.40
- AVG Volume (30 Days)
- PTGX 949.2K
- BNL 1.5M
- Earning Date
- PTGX 08-05-2025
- BNL 07-30-2025
- Dividend Yield
- PTGX N/A
- BNL 7.24%
- EPS Growth
- PTGX N/A
- BNL N/A
- EPS
- PTGX 0.86
- BNL 0.60
- Revenue
- PTGX $207,801,000.00
- BNL $435,124,000.00
- Revenue This Year
- PTGX N/A
- BNL $4.15
- Revenue Next Year
- PTGX $53.09
- BNL $5.26
- P/E Ratio
- PTGX $61.45
- BNL $26.68
- Revenue Growth
- PTGX N/A
- BNL 1.37
- 52 Week Low
- PTGX $32.50
- BNL $13.96
- 52 Week High
- PTGX $60.60
- BNL $19.15
- Technical
- Relative Strength Index (RSI)
- PTGX 53.99
- BNL 48.41
- Support Level
- PTGX $49.38
- BNL $15.79
- Resistance Level
- PTGX $51.51
- BNL $16.37
- Average True Range (ATR)
- PTGX 2.02
- BNL 0.27
- MACD
- PTGX -0.39
- BNL -0.04
- Stochastic Oscillator
- PTGX 46.09
- BNL 41.24
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About BNL Broadstone Net Lease Inc.
Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.